JMichaelMaloneyIIIMD

PubMed

• These dermatological disorders share the features of being caused by hyperactivity of androgen within the pilosebaceous follicle, and although not life threatening are...
  Maloney Jm> ;American Journal of Clinical Dermatology. 2011 Sep 6
• 13 citations
  A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris:...
  Maloney Jm, Dietze P, Watson D, Niknian M, Lee-Rugh S, Sampson-Landers C, Korner P> ;Journal of Drugs in Dermatology. 2009 Sep 1
• 49 citations
  Treatment of Acne Using a 3-Milligram Drospirenone/20-Microgram Ethinyl Estradiol Oral Contraceptive Administered in a 24/4 Regimen: A Randomized Controlled Trial
  J Michael Maloney, Peter Dietze, David Watson, Minoo Niknian, Sooji Lee-Rugh, Carole Sampson-Landers, Paul Korner> ;Obstetrics and Gynecology. 2008 Oct 1
• 38 citations
  Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment.
  Anne W. Lucky, Maloney Jm, Roberts J, Susan C. Taylor, Terry Jones, Mark Ling, Garrett S> ;Journal of Drugs in Dermatology. 2007 Oct 1
• Implantable microchips for controlled drug delivery.
  Maloney, J.M., Santini, J.T.> ;Conf Proc IEEE Eng Med Biol Soc. 2004
• Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
  Shalita, A.R., Chalker, D.K., Griffith, R.F., Herbert, A.A., Hickman, J.G., Maloney, J.M., Miller, B.H., Tschen, E.H., Chandraratna, R.A., Gibson, J.R., Lew-Kaya, D.A....> ;Cutis. 1999 Jun
• Current therapy for cutaneous melanoma.
  Maloney, J.M.> ;J Am Acad Dermatol. 1996 Feb
• Join now to see all